News and Publications

Histofy and Source BioScience Announce Strategic Partnership to Advance AI-Powered Pathology in the UK Coventry & Nottingham, UK (6 May 2025) — Histofy, a leading UK based pathology AI company...

Cancer Research Horizons non-exclusively licenses multi-modal S:CORT dataset to enable Histofy to develop AI-based digital pathology tools that stratify colorectal cancer patients based on risk and predict treatment response. These...

Histofy, an AI-driven leader in histopathology solutions, is excited to announce a new collaboration with Haukeland University Hospital (HUH), one of Norway’s premier medical institutions. The partnership aims to address...

Histofy, a leader in the development of transparent AI solutions for pathology, proudly announces the formation of its Scientific Advisory Board. This milestone reflects Histofy’s commitment to integrating world-class expertise...

Lumiares, a Belgium-based healthtech venture capital fund, announces an investment in Histofy, a University of Warwick spin-out dedicated to the creation of transparent AI solutions for cellular pathology. Ghent, Belgium...